Literature DB >> 10336126

High and low responders to novelty: effects of a catecholamine synthesis inhibitor on novelty-induced changes in behaviour and release of accumbal dopamine.

T Saigusa1, T Tuinstra, N Koshikawa, A R Cools.   

Abstract

The purpose of the present study was two-fold: (i) to investigate to what extent novelty, i.e. a novel cage with slightly larger dimensions than the home cage and lacking the floor covering that was originally present, produced behavioural effects in high responders to novelty and low responders to novelty that could be correlated with the extracellular amount of accumbal dopamine, using the microdialysis technique, and (ii) to establish the ability of the catecholamine synthesis inhibitor alpha-methyl-p-tyrosine to inhibit the novelty-induced responses in high and low responders. The difference in the behavioural response to novelty between the high and low responders was limited to walking, which lasted significantly longer in high responders than in low responders. The novelty-induced increase in extracellular concentration of accumbal dopamine was significantly greater in high responders than in low responders; moreover, the shape of the growth curves differed between high and low responders. The behavioural changes did not correlate with the neurochemical effects, which outlasted the duration of the novelty-induced behavioural arousal. It is hypothesized that this long-lasting increase in accumbal dopamine produces "adaptive changes" that help and/or allow the animal to incorporate knowledge about the condition that it experienced. When the nucleus accumbens was perfused with alpha-methyl-p-tyrosine for a period of 40 min, given at the same time as the transfer of the rat to the novel cage, it reduced the novelty-induced increase in walking in the high responders, but did not alter the novelty-induced behaviour of low responders. Finally, alpha-methyl-p-tyrosine reduced the novelty-induced increase in the release of accumbal dopamine in high responders, but enhanced it in low responders. The present neurochemical data are discussed in view of the outcome of earlier reported pharmacobehavioural studies on the neurochemical state of the nucleus accumbens of non-challenged versus challenged high and low responders. It is hypothesized that, in the high responder, exposure to novelty enhances the release of accumbal dopamine from reserpine-resistant, alpha-methyl-p-tyrosine-sensitive pools that are under the stimulatory control of beta-adrenergic receptors in the nucleus accumbens, and that, in the low responder, exposure to novelty enhances the release of accumbal dopamine from reserpine-sensitive, alpha-methyl-p-tyrosine-resistant pools that are under the inhibitory control of alpha-adrenergic receptors in the nucleus accumbens.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10336126     DOI: 10.1016/s0306-4522(98)00275-9

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  16 in total

1.  Novelty-elicited mismatch negativity in patients with schizophrenia on admission and discharge.

Authors:  I Grzella; B W Müller; R D Oades; S Bender; U Schall; D Zerbin; J Wolstein; G Sartory
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

2.  Activity-regulated cytoskeleton-associated protein (Arc/Arg3.1) regulates anxiety- and novelty-related behaviors.

Authors:  Rachel D Penrod; Jaswinder Kumar; Laura N Smith; Daniel McCalley; Todd B Nentwig; Brandon W Hughes; Gabriella M Barry; Kelsey Glover; Makoto Taniguchi; Christopher W Cowan
Journal:  Genes Brain Behav       Date:  2019-04-15       Impact factor: 3.449

Review 3.  Individual differences and social influences on the neurobehavioral pharmacology of abused drugs.

Authors:  M T Bardo; J L Neisewander; T H Kelly
Journal:  Pharmacol Rev       Date:  2013-01-23       Impact factor: 25.468

4.  Investigation on acetylcholine, aspartate, glutamate and GABA extracellular levels from ventral hippocampus during repeated exploratory activity in the rat.

Authors:  L Bianchi; C Ballini; M A Colivicchi; L Della Corte; M G Giovannini; G Pepeu
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

5.  Dopamine and glutamate release in the dorsolateral caudate putamen following withdrawal from cocaine self-administration in rats.

Authors:  Amanda Gabriele; Alejandra M Pacchioni; Ronald E See
Journal:  Pharmacol Biochem Behav       Date:  2012-09-28       Impact factor: 3.533

6.  Exposure to pups influences the strength of maternal motivation in virgin female rats.

Authors:  Katharine M Seip; Joan I Morrell
Journal:  Physiol Behav       Date:  2008-09-09

7.  Accumbal noradrenaline that contributes to the alpha-adrenoceptor-mediated release of dopamine from reserpine-sensitive storage vesicles in the nucleus accumbens is derived from alpha-methyl-para-tyrosine-sensitive pools.

Authors:  M M M Verheij; A R Cools
Journal:  J Neural Transm (Vienna)       Date:  2009-02-17       Impact factor: 3.575

8.  Emotional response in dopamine D2L receptor-deficient mice.

Authors:  Dubravka Hranilovic; Maja Bucan; Yanyan Wang
Journal:  Behav Brain Res       Date:  2008-09-18       Impact factor: 3.332

9.  Role of alpha adrenoceptors in the nucleus accumbens in the control of accumbal noradrenaline efflux: a microdialysis study with freely moving rats.

Authors:  Y Aono; T Saigusa; S Watanabe; T Iwakami; N Mizoguchi; H Ikeda; K Ishige; K Tomiyama; Y Oi; K Ueda; W-D Rausch; J L Waddington; Y Ito; N Koshikawa; A R Cools
Journal:  J Neural Transm (Vienna)       Date:  2007-05-29       Impact factor: 3.575

10.  Individual differences in the sensitivity to serotonergic drugs: a pharmacobehavioural approach using rats selected on the basis of their response to novelty.

Authors:  Michel M M Verheij; Jesse V Veenvliet; Tom Groot Kormelink; Maaike Steenhof; Alexander R Cools
Journal:  Psychopharmacology (Berl)       Date:  2009-05-12       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.